-
May 17, 2013
Brocade badly needs to prove that it can grow again.
-
May 15, 2013
Cummins is still bottoming, but the Street is already thinking recovery
-
May 15, 2013
Even with its problems and challenges, BP seems too cheap today
-
May 15, 2013
Valspar's market share and performance suggest the stock has recovered far enough.
-
May 10, 2013
Middleby continues to gain share and expand its market opportunities in an under-innovative industry.
-
May 10, 2013
Dendreon looks increasingly irrelevant as the medical community moves on from Provenge.
-
May 10, 2013
Investors aren't sold on Nvidia's strategy, and that shows in the stock price.
-
May 09, 2013
Teva's partnership with Alexza looks like an expensive gamble.
-
May 09, 2013
Groupon still has a lot of work to do to reassure the Street that this business model is viable
-
May 09, 2013
After a big quarterly miss, can investors afford to trust the long-term opportunity at Aruba?
-
May 08, 2013
Amgen really needs the pipeline to come through to support this valuation.
-
May 07, 2013
China’s growing consumer class isn’t just spending their hard earned money of fast food, TVs and designer handbags. ...
-
May 07, 2013
Broadcom has multiple appealing growth opportunities, but also competitive challenges to address.
-
May 06, 2013
BMC's sluggish growth results in a takeout bid that doesn't seem to fully value the company.
-
May 03, 2013
Teva's present-day momentum is weak, but the value could appeal to patient long-term investors.
-
May 01, 2013
The traditional utility sector has become a happy hunting ground for income seekers.
-
April 29, 2013
Expectations are the bigger issue for Covidien, as underlying growth is still pretty good on a relative basis.
-
April 29, 2013
Total's performance looked pretty typical for the sector, but the company has a lot still to prove.
-
April 26, 2013
Chevron seems underrated and undervalued relative to the likes of Exxon.
-
April 25, 2013
Disappointing margins dent 3M's all-weather credentials.
